See also this year's filing and all EDGAR filings for this company.
PDF Report 0000949699_2013_Pharmacyclics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000949699, Pharmacyclics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 346,492,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,403,000 |
| 3 | remainder_Assets | 2,234,000 |
| 4 | LiabilitiesCurrent | 29,257,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 63,346,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,575,000 |
| 9 | ResearchAndDevelopmentExpense | 54,537,000 |
| 10 | remainder_Expenses | 39,000 |
| 11 | remainder_Revenues | 81,990,000 |
| 12 | remainder_NetIncome | 147,000 |
| 13 | remainder_ComprehensiveNetIncome | 12,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 355,129,000 |
| 1 | Liabilities | 92,603,000 |
| 2 | Expenses | 70,151,000 |
| 3 | Revenues | 81,990,000 |
| 4 | StockholdersEquity | 262,526,000 |
| 5 | NetIncome | 11,986,000 |
| 6 | ComprehensiveNetIncome | 11,992,000 |
| 7 | BaseVar | 300,016,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.61 |
| 9 | EconomicCapitalRatio | 3.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
